Corrigendum to 'L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells': [Free Radic. Biol. Med. 95 (2016) 200-208].
Jung SA, Lee DH, Moon JH, Hong SW, Shin JS, Hwang IY, Shin YJ, Kim JH, Gong EY, Kim SM, Lee EY, Lee S, Kim JE, Kim KP, Hong YS, Lee JS, Jin DH, Kim T, Lee WJ.
Jung SA, et al. Among authors: kim kp, kim t, kim sm, kim je, kim jh.
Free Radic Biol Med. 2016 Aug;97:620. doi: 10.1016/j.freeradbiomed.2016.07.017. Epub 2016 Jul 27.
Free Radic Biol Med. 2016.
PMID: 27476024
No abstract available.